Search

for
Search:

GlossaryACTH Stimulation Test (ACTH Test)

measures adrenal gland response to synthetic ACTH injection

The ACTH Stimulation Test, also known as the Adrenocorticotropic Hormone Stimulation Test, is a diagnostic procedure used to assess the functioning of the adrenal glands. During the test, synthetic ACTH is administered to stimulate the adrenal glands to produce cortisol, and blood samples are taken to measure cortisol levels before and after the injection. This helps diagnose conditions like Addison's disease or adrenal insufficiency.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 1000+ results

Results of Clinical Examinations, Laboratory Tests, and Ultrasonography in Dogs with Pituitary-Dependent Hyperadrenocorticism Treated with Trilostane

research Results of Clinical Examinations, Laboratory Tests, and Ultrasonography in Dogs with Pituitary-Dependent Hyperadrenocorticism Treated with Trilostane

116 citations , April 2002 in “American journal of veterinary research”

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

research Hyperadrenocorticism Associated with Adrenocortical Tumor or Nodular Hyperplasia of the Adrenal Gland in Ferrets: 50 Cases (1987-1991)

83 citations , July 1993 in “Journal of the American Veterinary Medical Association”

Diagnosis of adrenal issues in ferrets should use symptoms, ultrasound, and surgery, not ACTH tests.

Urinary 5-Ene-Steroid Excretion in Non-Classical Congenital Adrenal Hyperplasia Due to 3β-Hydroxysteroid Dehydrogenase Deficiency

research Urinary 5-Ene-Steroid Excretion in Non-Classical Congenital Adrenal Hyperplasia Due to 3β-Hydroxysteroid Dehydrogenase Deficiency

3 citations , May 1990 in “Journal of Steroid Biochemistry”

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

research Clinical, Biochemical, and Molecular Characteristics of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

December 2024 in “Journal of Clinical Research in Pediatric Endocrinology”

21-hydroxylase deficiency causes hormone imbalances leading to various symptoms, and diagnosis involves clinical and genetic tests.

Adrenal 21-Hydroxylase Gene Mutations in Slovenian Hyperandrogenic Women: Evaluation of Corticotrophin Stimulation and HLA Polymorphisms in Screening for Carrier Status

research Adrenal 21-Hydroxylase Gene Mutations in Slovenian Hyperandrogenic Women: Evaluation of Corticotrophin Stimulation and HLA Polymorphisms in Screening for Carrier Status

19 citations , August 1999 in “European journal of endocrinology”

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

View more "acth test" in research →

Community Join

4 / 4 results

community 2 years on treatment (stack update)

in Progress Pictures 462 upvotes 8 months ago

A user shared their hair regrowth progress using Dutasteride, topical Minoxidil, Spironolactone, and Estradiol Valerate injections as part of hormone replacement therapy for transitioning. They experienced significant hair improvement and personal satisfaction but caution against this approach for non-transitioning individuals due to irreversible changes.

community Result of my cortisol, prolactin, testosterone, ACTH blood test,

in Update 1 week ago

OP is using 5% minoxidil and a foligain supplement for hair loss, with blood test results showing high cortisol levels. OP is considering starting finasteride, while another user shares their experience with finasteride and hair loss challenges due to malabsorption issues.

community How does hair loss and recovery work?

in Chat 12 upvotes 1 year ago

Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

community EU Shouldn't Ban Fin & Dut: PFS is NOT REAL.

in Research/Science 10 upvotes 11 months ago

Finasteride and Dutasteride do not cause depression or "Post Finasteride Syndrome," with concerns often linked to the nocebo effect and preexisting mental health issues. The EU is unlikely to ban these drugs, but access may become more restricted due to ongoing debates.